Ensembl Variant Effect Predictor
Ensembl Variant Effect Predictor annotates and predicts the functional consequences of genomic variants across coding and non-coding regions to support variant interpretation and prioritization.
Key Features:
- Variant types supported: Determines effects for single nucleotide polymorphisms (SNPs), insertions, deletions, copy number variations (CNVs), and structural variants.
- Impact on genomic elements: Assigns predicted impacts on genes, transcripts, protein sequences, and regulatory regions.
- Annotation sources: Leverages an extensive collection of genomic annotations to inform effect predictions.
- Analysis scope: Performs annotation and analysis across both coding and non‑coding regions of the genome.
- Reproducibility: Emphasizes reproducible analyses to enable consistent results across studies.
Scientific Applications:
- Functional consequence annotation: Elucidates functional consequences of genetic variation at gene, transcript, protein, and regulatory levels.
- Variant prioritization: Prioritizes variants based on predicted impacts and potential biological significance.
- Disease and phenotype studies: Supports interpretation of variants in health- and disease-related genomics research.
- General research designs: Applicable to a range of study designs aimed at understanding variant effects.
Methodology:
Uses genomic annotations to assign effects on genes, transcripts, protein sequences, and regulatory regions and produces annotations for analysis and prioritization with an emphasis on reproducibility.
Topics
Details
- License:
- Apache-2.0
- Operating Systems:
- Linux, Windows, Mac
- Programming Languages:
- Perl
- Added:
- 8/11/2018
- Last Updated:
- 11/24/2024
Operations
Publications
McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, Flicek P, Cunningham F. The Ensembl Variant Effect Predictor. Genome Biology. 2016;17(1). doi:10.1186/s13059-016-0974-4. PMID:27268795. PMCID:PMC4893825.
PMID: 27268795
PMCID: PMC4893825
Funding: - Wellcome Trust (GB): WT095908 and WT098051
- Seventh Framework Programme (BE): 200754 (GEN2PHEN), 222664 (Quantomics)
- European Union’s Horizon 2020 research and innovation programme: 634143 (MedBioinformatics)